111 related articles for article (PubMed ID: 20955378)
1. Immunohistochemical expression of p16(INK4A) protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: study on a series with long-term follow-up.
Montebugnoli L; Cervellati F; Cocchi R; Farnedi A; Pennesi MG; Flamminio F; Foschini MP
Histopathology; 2010 Oct; 57(4):528-34. PubMed ID: 20955378
[TBL] [Abstract][Full Text] [Related]
2. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
Greer RO; Meyers A; Said SM; Shroyer KR
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
[TBL] [Abstract][Full Text] [Related]
3. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
4. Expression of p27, p21(WAF/Cip1), and p16(INK4a) in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma.
Queiroz AB; Focchi G; Dobo C; Gomes TS; Ribeiro DA; Oshima CT
Anticancer Res; 2010 Jul; 30(7):2799-803. PubMed ID: 20683015
[TBL] [Abstract][Full Text] [Related]
5. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
6. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
[TBL] [Abstract][Full Text] [Related]
7. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
Suzuki H; Sugimura H; Hashimoto K
J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
[TBL] [Abstract][Full Text] [Related]
8. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
[TBL] [Abstract][Full Text] [Related]
9. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia.
Cunningham LL; Pagano GM; Li M; Tandon R; Holm SW; White DK; Lele SM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):77-81. PubMed ID: 16831676
[TBL] [Abstract][Full Text] [Related]
12. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
Muirhead DM; Hoffman HT; Robinson RA
J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
[TBL] [Abstract][Full Text] [Related]
13. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
Auepemkiate S; Thongsuksai P; Boonyaphiphat P
J Med Assoc Thai; 2006 Sep; 89(9):1460-5. PubMed ID: 17100385
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
[TBL] [Abstract][Full Text] [Related]
15. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women.
Missaoui N; Trabelsi A; Hmissa S; Fontanière B; Yacoubi MT; Mokni M; Korbi S; Frappart L
Pathol Res Pract; 2010 Aug; 206(8):550-5. PubMed ID: 20400236
[TBL] [Abstract][Full Text] [Related]
16. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer.
Angiero F; Gatta LB; Seramondi R; Berenzi A; Benetti A; Magistro S; Ordesi P; Grigolato P; Dessy E
Anticancer Res; 2010 Sep; 30(9):3435-40. PubMed ID: 20944119
[TBL] [Abstract][Full Text] [Related]
17. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical analysis of cell cycle-associated proteins p27 in oral cancer and precancer].
Hou B; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Feb; 41(2):102-5. PubMed ID: 16640935
[TBL] [Abstract][Full Text] [Related]
19. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
20. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
Shahnavaz SA; Bradley G; Regezi JA; Thakker N; Gao L; Hogg D; Jordan RC
Cancer Res; 2001 Mar; 61(6):2371-5. PubMed ID: 11289098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
